Panbela Therapeutics, Inc. - Common Stock (NQ:PBLA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 6, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Panbela Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q1 2024 ↗

May 15, 2024

PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

PBLA Stock Earnings: Panbela Therapeutics Misses EPS for Q4 2023 ↗

March 26, 2024

PBLA stock results show that Panbela Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Recap: Panbela Therapeutics Q4 Earnings ↗

March 26, 2024

Via Benzinga

Earnings Preview: Panbela Therapeutics ↗

March 25, 2024

Via Benzinga

Top 4 Health Care Stocks That Are Preparing To Pump This Month ↗

February 23, 2024

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 14, 2024

Via Benzinga

(PBLA) - Analyzing Panbela Therapeutics's Short Interest ↗

January 24, 2024

Via Benzinga

What's Going On With Panbela Therapeutics Stock Today? ↗

January 30, 2024

Panbela Therapeutics announced acceptance of SBP-101 abstract for presentation and disclosed details of a public offering, expecting approximately $9.0 million in gross proceeds.

Via Benzinga

Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher ↗

January 29, 2024

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to...

Via Benzinga

Topics Stocks

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 29, 2024

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 29, 2024

Via Benzinga

Dow Edges Lower; Cardlytics Shares Jump ↗

January 29, 2024

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday. The Dow traded down 0.04% to 38,093.41 while the NASDAQ rose 0.15% to 4,891.83. The S&P...

Via Benzinga

Topics Stocks

US Stocks Edge Higher; Amazon And iRobot Agree To Terminate Acquisition Deal ↗

January 29, 2024

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 25 points on Monday. Following the market opening Monday, The Dow traded up 0.07% to 38,134.80 while the NASDAQ...

Via Benzinga

Topics Stocks

Why Is Aclarion (ACON) Stock Down 16% Today? ↗

January 29, 2024

Aclarion stock is falling on Monday after the company issued 500,000 shares of ACON to cover principal and accrued interest from notes.

Via InvestorPlace

Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today? ↗

January 29, 2024

Panbela Therapeutics stock is falling on Monday after pricing a public offering for PBLA shares well below its price closing price.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 29, 2024

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket ↗

January 29, 2024

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) shares rose sharply in today's pre-market trading after Jefferies upgraded the stock from Hold to Buy and raised its price target from $14 to $20.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 29, 2024

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 26, 2024

Via Benzinga

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 26, 2024

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 26, 2024

Via Benzinga

What's Going On With Panbela Therapeutics Stock? ↗

January 26, 2024

Panbela Therapeutics has a float of only 480,324 shares after the company effected a 1-for-20 reverse split on Jan. 18. Heavy trading volume combined with the small float may be contributing to the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 26, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 26, 2024

Pre-market stock movers are worth checking out on Friday as we get into all of the biggest news affecting shares this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 23, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 23, 2024

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!

Via InvestorPlace

Overview Of Value Stocks In The Healthcare Sector ↗

January 15, 2024

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

January 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 27, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.